The Phase 2b ADAPTIVE trial is a randomized, placebo-controlled dose-finding study designed to evaluate the efficacy and safety of various dose regimens of IMG-007 in adults with moderate-to-severe AD ...
-- 63% complete response (CR) rate at any time (n=62); -- 56% CR rate at 3 months (n=62); -- 62% CR rate at 6 months (n=37), with 4 patients having successfully converted to CR post reinduction; and - ...
Join us Dec. 8 for Federal News Network's Industry Exchange Cloud event where top technology leaders will discuss latest cloud breakthroughs and strategies for the future. Register now!
India must prepare for a Pakistan that will continue to prioritise conflict and control over stability and reform. The 27th ...
Survival World on MSN
Armed Citizens Spark Controversy With ‘Open Carry Audit’ at Florida State University
Since September 25, open carry without a permit has been legal in most public spaces, with familiar carve-outs for “sensitive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback